Details of the Drug Reposition

General Information of This Drug (ID: DMV9FLB)

Drug Name
CNSA-001   DMV9FLB
Drug Type
Small molecular drug

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Gastroparesis DISDW0SR DA41.00 Phase 2 [1]
------------------------------------------------------------------------------------
1 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Hyperphenylalaninemia DISCQU4G 5C50 Phase 1/2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03712124) A Study of CNSA-001 in Women With Diabetic Gastroparesis. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT03519711) A Study of CNSA-001 in Primary Tetrahydrobiopterin (BH4) Deficient Participants With Hyperphenylalaninemia. U.S. National Institutes of Health.